BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 9038723)

  • 1. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
    Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
    Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) in the regulation of the immune complex-elicited respiratory burst of polymorphonuclear leukocytes in whole blood.
    Nielsen CH; Antonsen S; Matthiesen SH; Leslie RG
    Eur J Immunol; 1997 Nov; 27(11):2914-9. PubMed ID: 9394818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of opsonized immune complexes with whole blood cells: binding to erythrocytes restricts complex uptake by leucocyte populations.
    Nielsen CH; Svehag SE; Marquart HV; Leslie RG
    Scand J Immunol; 1994 Aug; 40(2):228-36. PubMed ID: 8047846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
    Paccaud JP; Carpentier JL; Schifferli JA
    Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (CR1, CD35) on human erythrocytes.
    Gibson NC; Waxman FJ
    Clin Immunol Immunopathol; 1994 Feb; 70(2):104-13. PubMed ID: 8299225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
    Craig ML; Waitumbi JN; Taylor RP
    J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement coating of erythrocytes is reduced following their interaction with neutrophils in vitro without loss of complement receptor 1 (CR1).
    Imrie HJ; Jones DR
    Clin Exp Immunol; 1997 Jul; 109(1):217-22. PubMed ID: 9218847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key role of the number of complement receptor 1 on erythrocytes for binding of Escherichia coli to erythrocytes and for leukocyte phagocytosis and oxidative burst in human whole blood.
    Brekke OL; Christiansen D; Kisserli A; Fure H; Dahl JA; Donvito B; Reveil B; Ludviksen JK; Tabary T; Mollnes TE; Cohen JHM
    Mol Immunol; 2019 Oct; 114():139-148. PubMed ID: 31352230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of immune complexes to human red cells: complement requirements and fate of the RBC-bound IC after interaction with human phagocytic cells.
    Sherwood TA; Virella G
    Clin Exp Immunol; 1986 Apr; 64(1):195-204. PubMed ID: 3731526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune complexes bind preferentially to specific subpopulations of human erythrocytes.
    Cosio FG; Shen XP; Hebert LA
    Clin Immunol Immunopathol; 1990 Jun; 55(3):337-54. PubMed ID: 2140304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
    Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
    Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced binding of immune complexes processed by erythrocyte CR1 (CD 35) receptors to purified CR2 (CD 21) receptors from tonsillar mononuclear cells.
    Rask R; Rasmussen JM; Jepsen HH; Svehag SE
    APMIS; 1989 Apr; 97(4):374-80. PubMed ID: 2524204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
    Taylor RP; Pocanic F; Reist C; Wright EL
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W; Burdick G; Carl V; Lachmann PJ
    J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
    Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
    Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
    Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of processing by erythrocyte C3b/C4b receptors (CR1) on binding of immune complexes to Raji cells and polymorphonuclear granulocytes.
    Rasmussen JM; Jepsen HH; Svehag SE
    Scand J Immunol; 1987 Oct; 26(4):437-44. PubMed ID: 2961050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
    Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
    Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.